Literature DB >> 19376173

Tailored drug release from biodegradable stent coatings based on hybrid polyurethanes.

Qiongyu Guo1, Pamela T Knight, Patrick T Mather.   

Abstract

Highly adjustable and precisely controllable drug release from a biodegradable stent coating was achieved using a unique family of nanostructured hybrid polyurethanes. These polyurethanes are polyhedral oligosilsesquioxane thermoplastic polyurethanes (POSS TPUs) featuring alternating multiblock structures formed by nanostructured hard segments of POSS and biodegradable soft segments of a polylactide/caprolactone copolymer (P(DLLA-co-CL)) incorporating polyethylene glycol (PEG) covalently. POSS aggregated to form crystals serving as physical crosslinks on the nanometer scale, while the soft segments were designed carefully to modulate the drug release rate from the POSS TPU stent coatings in PBS buffer solution, with 90% of the drug releasing from within half a day to about 90 days. In order to interpret the underlying drug release mechanisms, an approximation model capable of describing the entire drug release process was developed. This model is based on Fickian diffusional transport, but also takes into account the polymer degradation and/or swelling of the coating, depending on the dominance of the degradation/swelling behavior compared to that of the diffusion characteristics. A general methodology was utilized for statistically fitting the drug release curves from the POSS TPU stent coatings using the model. We observed that the fitted initial drug release diffusion coefficient covered more than three orders of magnitude, depending on the polymer glass transition temperature (T(g)), according to a modified Williams-Landel-Ferry (WLF) equation. In addition, two additional rate constants describing the impact of degradation and swelling on drug elution were determined and found to be consistent with independent measurements. Our results clearly show that the studied hybrid polyurethane family allows a drug release rate that is effectively manipulated through variation in polymer T(g), degradation rate, and thickness increment rate.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19376173     DOI: 10.1016/j.jconrel.2009.04.016

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  14 in total

Review 1.  An Overview of In Vitro Drug Release Methods for Drug-Eluting Stents.

Authors:  Navideh Abbasnezhad; Nader Zirak; Stéphane Champmartin; Mohammadali Shirinbayan; Farid Bakir
Journal:  Polymers (Basel)       Date:  2022-07-05       Impact factor: 4.967

2.  Degradable poly(ethylene glycol) (PEG)-based hydrogels for spatiotemporal control of siRNA/nanoparticle delivery.

Authors:  Yuchen Wang; Sue Zhang; Danielle S W Benoit
Journal:  J Control Release       Date:  2018-08-03       Impact factor: 9.776

3.  Avidity-controlled delivery of angiogenic peptides from injectable molecular-recognition hydrogels.

Authors:  Widya Mulyasasmita; Lei Cai; Yuki Hori; Sarah C Heilshorn
Journal:  Tissue Eng Part A       Date:  2014-02-03       Impact factor: 3.845

4.  Development of hydrophobized alginate hydrogels for the vessel-simulating flow-through cell and their usage for biorelevant drug-eluting stent testing.

Authors:  Beatrice Semmling; Stefan Nagel; Katrin Sternberg; Werner Weitschies; Anne Seidlitz
Journal:  AAPS PharmSciTech       Date:  2013-08-06       Impact factor: 3.246

5.  Fabrication of Polymeric Coatings with Controlled Microtopographies Using an Electrospraying Technique.

Authors:  Qiongyu Guo; Jason P Mather; Pine Yang; Mark Boden; Patrick T Mather
Journal:  PLoS One       Date:  2015-06-19       Impact factor: 3.240

6.  Octa-ammonium POSS-conjugated single-walled carbon nanotubes as vehicles for targeted delivery of paclitaxel.

Authors:  Naghmeh Naderi; Seyed Y Madani; Afshin Mosahebi; Alexander M Seifalian
Journal:  Nano Rev       Date:  2015-09-08

7.  Moxifloxacin in situ gelling microparticles-bioadhesive delivery system.

Authors:  Qiongyu Guo; Ahmed Aly; Oliver Schein; Morgana M Trexler; Jennifer H Elisseeff
Journal:  Results Pharma Sci       Date:  2012-09-25

Review 8.  Polyhedral Oligomeric Silsesquioxane (POSS)-Containing Polymer Nanocomposites.

Authors:  Ebunoluwa Ayandele; Biswajit Sarkar; Paschalis Alexandridis
Journal:  Nanomaterials (Basel)       Date:  2012-12-06       Impact factor: 5.076

Review 9.  Sustained Release Drug Delivery Applications of Polyurethanes.

Authors:  Michael B Lowinger; Stephanie E Barrett; Feng Zhang; Robert O Williams
Journal:  Pharmaceutics       Date:  2018-05-09       Impact factor: 6.321

10.  Mechanical Properties and Biological Behavior of 3D Matrices Produced by Electrospinning from Protein-Enriched Polyurethane.

Authors:  Vera S Chernonosova; Alexander A Gostev; Yun Gao; Yuriy A Chesalov; Alexey V Shutov; Evgeniy A Pokushalov; Andrey A Karpenko; Pavel P Laktionov
Journal:  Biomed Res Int       Date:  2018-06-26       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.